Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Clontech Laboratories Incorporated

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clontech joins a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Clontech’s mission is to develop high-quality innovative tools and services to accelerate discovery.

Innovation

In order to maintain our position as an industry leader, we foster an environment of collaboration and discovery for our research scientists and with the research community at large. Our scientists are leaders in their fields and publish regularly in leading peer-reviewed journals such as Biotechniques, Science, and PNAS. Clontech holds over 30 patents and offers novel tools for studying gene expression analysis, subcellular localization, apoptosis, and signal transduction. In addition, our scientists have authored guides and publications that are industry standards in technologies ranging from PCR to gene expression profiling to yeast two-hybrid systems.

We actively seek research and business partnerships with industry innovators and leaders. Our research and development efforts have resulted in award winning technologies and the introduction of novel tools to the market. Clontech introduced the first commercially available antibody microarray, a unique tool that allows users to study hundreds of cellular proteins in one experiment. We have also received R&D 100 awards for our fluorescent proteins, apoptosis detection systems, cDNA arrays, tet-regulated gene expression systems, and retroviral expression systems.


Contact Details:
1290 Terra Bella Ave.
Mountain View
CA
94043
United States of America
Tel:650-919-7300
Fax:650-424-1064
Email:orders@clontech.com
WWW:

www.clontech.com




Loading...

Recent Publications by Clontech Laboratories Incorporated:

Affinity chromatography of phosphorylated proteins.
This chapter covers the use of immobilized metal ion affinity...
17th October, 2008
Clontech Laboratories, Inc., Mountain View, CA, USA. Methods Mol Biol. 2008;421:285-94.
Antibody arrays for determination of relative protein abundances.
As a large number of genome-sequencing projects reached completion, the...
21st May, 2008
Clontech Laboratories, Mountain View, CA, USA. Methods Mol Biol. 2008;441:129-51.
DOI Direct Link
ProteoTuner: a novel system with rapid kinetics enables reversible control of protein levels in cells and organisms.
As a large number of genome-sequencing projects reached completion, the...
1st May, 2008
Clontech Laboratories, Inc.. Biotechniques. 2008 Mar;44(3):432-3.
DOI Direct Link
Overview of genetic reporter systems.
One method to gauge changes in transcription is to link a presumed...
29th March, 2008
Clontech Laboratories, Inc., Palo Alto, California, USA. Curr Protoc Mol Biol. 2001 May;Chapter 9:Unit9.6.
DOI Direct Link
Large-scale, high-throughput validation of short hairpin RNA sequences for RNA interference.
A method for high-throughput cloning and analysis of short hairpin RNAs...
22nd June, 2006
Clontech Laboratories, Mountain View, CA 94043, USA. J Biomol Screen. 2006 Apr;11(3):236-46. Epub 2006 Feb 20.
DOI Direct Link

View more Clontech Laboratories Incorporated research publications.

BioNews Results for Clontech Laboratories Incorporated:

Impax Laboratories Confirms Patent Challenge Relating to TRICOR(R) 48mg and 145mg Tablets
Pharmacy Choice:  Nov 22 2009 1:21PM Matching: laboratories
(Taiwan) Innovation and excellence honored at awards event: Formosa Laboratories wins top prize, GaleMed comes
BiotechEast:  Nov 22 2009 7:49AM Matching: laboratories
Even a small study on Zetia, Vytorin makes impact
Home News Tribune:  Nov 21 2009 2:52AM Matching: laboratories
FDA review diet drug risks
Straits Times:  Nov 21 2009 1:27AM Matching: laboratories
IMPAX Laboratories, Inc. (IPXL) Drives Stronger Performance with IBM Business Analytics
BioSpace:  Nov 21 2009 12:39AM Matching: laboratories
Promote your company here: BioNewsCast - Press Release Distribution

View more Clontech Laboratories Incorporated news.

Clontech Laboratories Incorporated Patents:

US Patent No.Title
5942610 Non-nucleoside 1,3-diol reagents and their use to label or modify synthetic oligonucleotides
6287768 Polymeric arrays and methods for their use in binding assays
6300073 One step RT-PCR methods, enzyme mixes and kits for use in practicing the same
6306600 Rapidly degrading GFP-fusion proteins and methods of use
6352829 Methods of assaying differential expression

View more Clontech Laboratories Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 18 individuals from Clontech Laboratories Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 711 times since April 2007, the link to the organisation's website has been followed 99 times

Recent Search Terms used to find this page: clontech | clontech AND Xfect AND patent | clontech | clontech innovative tools to accelerate discovery | Clonetec laboratories | Clontech | clontech | clontech laboratories | clontech | .

Search for more companies in Mountain View

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Clontech Laboratories Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.